These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11794423)

  • 1. Use of thrombolytic therapy to treat heparin-refractory pulmonary embolism in a menstruating patient.
    Koch AZ; Abubaker J; Barnett VT; Chan LN
    Pharmacotherapy; 2002 Jan; 22(1):118-22. PubMed ID: 11794423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Thrombolytic therapy in pregnant woman with pulmonary embolism].
    Jensen HH; Søgaard K; Grande P; Langhoff-Roos J
    Ugeskr Laeger; 2009 May; 171(21):1776-8. PubMed ID: 19454200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic thrombolysis for acute pulmonary embolism.
    Bartel B
    Hosp Pract (1995); 2015; 43(1):22-7. PubMed ID: 25559613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prehospital thrombolysis of a massive pulmonary embolus.
    Perkins ZB; Mitchell C; Donald O
    Emerg Med J; 2008 May; 25(5):303-4. PubMed ID: 18434474
    [No Abstract]   [Full Text] [Related]  

  • 5. Thrombolytic therapy for pulmonary embolism.
    Dong B; Jirong Y; Liu G; Wang Q; Wu T
    Cochrane Database Syst Rev; 2006 Apr; (2):CD004437. PubMed ID: 16625603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombolytic Therapy by Tissue Plasminogen Activator for Pulmonary Embolism.
    Islam MS
    Adv Exp Med Biol; 2017; 906():67-74. PubMed ID: 27628004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombolysis for pulmonary embolism.
    Goldhaber SZ
    N Engl J Med; 2002 Oct; 347(15):1131-2. PubMed ID: 12374871
    [No Abstract]   [Full Text] [Related]  

  • 8. Thrombolysis for acute massive pulmonary embolism during pregnancy.
    Yap LB; Alp NJ; Forfar JC
    Int J Cardiol; 2002 Feb; 82(2):193-4. PubMed ID: 11853911
    [No Abstract]   [Full Text] [Related]  

  • 9. Recombinant tissue plasminogen activator for hemodynamically stable patients experiencing an acute pulmonary embolism: a meta-analysis.
    Liu Y; Lu Y; Song J; Li D; Liu H; Yang J; Zhao H
    Thromb Res; 2014 Jul; 134(1):50-6. PubMed ID: 24824292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful thrombolysis of submassive pulmonary embolism after bariatric surgery: expanding the indications and addressing the controversies.
    Pulipati RC; Lazzaro RS; Macura J; Savel RH
    Obes Surg; 2003 Oct; 13(5):792-6. PubMed ID: 14627480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant tissue plasminogen activator for both pulmonary and cerebral embolism.
    Yeguiayan JM; Benatru I; Guiu B; Taam JA; Albertini S; Freysz M; Giroud M
    Am J Emerg Med; 2011 Oct; 29(8):961.e1-4. PubMed ID: 21030188
    [No Abstract]   [Full Text] [Related]  

  • 12. Thrombolytic therapy for pulmonary embolism.
    Dong BR; Hao Q; Yue J; Wu T; Liu GJ
    Cochrane Database Syst Rev; 2009 Jul; (3):CD004437. PubMed ID: 19588357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombolytic therapy for massive pulmonary embolism in a patient with a known intracranial tumor.
    Han S; Chaya C; Hoo GW
    J Intensive Care Med; 2006; 21(4):240-5. PubMed ID: 16855059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombolytic therapy in patients with submassive pulmonary embolism.
    Ajani AE; Waksman R
    N Engl J Med; 2003 Jan; 348(4):357-9; author reply 357-9. PubMed ID: 12542063
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical efficacy and safety of thrombolytic treatment with reteplase in patients with intermediate-risk acute pulmonary embolism].
    Zhao HG; Wang SX; Lu ZN; Yan XX; Lyu ZC; Peng FH; Wu Y; Gao X; Hua L; Jing ZC; Xu XQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Apr; 45(4):314-317. PubMed ID: 28545283
    [No Abstract]   [Full Text] [Related]  

  • 16. Thrombolysis for massive pulmonary embolism in pregnancy: a case report.
    Fasullo S; Scalzo S; Maringhini G; Cannizzaro S; Terrazzino G; Paterna S; Di Pasquale P
    Am J Emerg Med; 2011 Jul; 29(6):698.e1-4. PubMed ID: 20708882
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical efficacy of low dose recombinant tissue-type plasminogen activator for the treatment of acute intermediate-risk pulmonary embolism.
    Zhang LY; Gao BA; Jin Z; Xiang GM; Gong Z; Zhang TT; Lu HF; Wang YQ; Gong Y; Lu C; Huang WL
    Saudi Med J; 2018 Nov; 39(11):1090-1095. PubMed ID: 30397707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombolysis of venous and arterial thrombosis by catheter-directed low-dose infusion of tissue plasminogen activator in children.
    Cannizzaro V; Berger F; Kretschmar O; Saurenmann R; Knirsch W; Albisetti M
    J Pediatr Hematol Oncol; 2005 Dec; 27(12):688-91. PubMed ID: 16344680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombolytic therapy for pulmonary embolism.
    Katchan BM
    Can J Surg; 2000 Dec; 43(6):411-6. PubMed ID: 11129828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of thrombolytic therapy in pulmonary embolism determined by MION-enhanced MRA: an experimental study in rabbits.
    Frank H; Loewe R; Loewe C; Oberhuber G; Schwaighofer B; Huber K; Weissleder R
    Invest Radiol; 1998 Dec; 33(12):853-7. PubMed ID: 9851818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.